Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$27.45−1.09 (-3.82%)
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Nanobiotix total assets
Total assets on the balance sheet at the end of each period.
Nanobiotix's total assets was €128.33M at Jun 30, 2026. For fiscal 2025 it was €67.76M, up 0.5% from the year before. The highest annual figure on record is €134.03M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €67.76M | +0.5% |
| FY2024 | Dec 31, 2024 | €67.42M | -28.2% |
| FY2023 | Dec 31, 2023 | €93.90M | +57.1% |
| FY2022 | Dec 31, 2022 | €59.77M | -41.3% |
| FY2021 | Dec 31, 2021 | €101.77M | -24.1% |
| FY2020 | Dec 31, 2020 | €134.03M | +138.5% |
| FY2019 | Dec 31, 2019 | €56.21M | +9.0% |
| FY2018 | Dec 31, 2018 | €51.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €128.33M | +48.1% |
| Q4 FY2025 | Dec 31, 2025 | €67.76M | -27.8% |
| Q2 FY2025 | Jun 30, 2025 | €45.17M | +11.8% |
| Q4 FY2024 | Dec 31, 2024 | €67.42M | +12.8% |
| Q2 FY2024 | Jun 30, 2024 | €86.68M | +7.5% |
| Q4 FY2023 | Dec 31, 2023 | €93.90M | -7.7% |
| Q2 FY2023 | Jun 30, 2023 | €40.41M | -67.4% |
| Q4 FY2022 | Dec 31, 2022 | €59.77M | -55.4% |
| Q2 FY2022 | Jun 30, 2022 | €80.62M | +43.4% |
| Q4 FY2021 | Dec 31, 2021 | €101.77M | +97.3% |
| Q2 FY2021 | Jun 30, 2021 | €123.92M | – |
| Q4 FY2020 | Dec 31, 2020 | €134.03M | – |
| Q4 FY2019 | Dec 31, 2019 | €56.21M | – |
| Q4 FY2018 | Dec 31, 2018 | €51.58M | – |
See a number that looks wrong?